688575.SS SHH
Shenzhen YHLO Biotech Co., Ltd.
1W: +0.9%
1M: +2.5%
3M: +14.8%
YTD: -22.9%
1Y: -33.1%
3Y: -43.5%
5Y: -65.2%
¥10.53 ($1.57)
+0.23 (+2.23%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$4.4B
+16.0% ▲
5Y CAGR: +32.6%
Total Liabilities
$1.7B
+34.6% ▲
5Y CAGR: +28.1%
Shareholders Equity
$2.8B
+7.7% ▲
5Y CAGR: +36.6%
Cash & Investments
$535M
-5.8% ▼
5Y CAGR: +28.8%
Total Debt
$880M
+58.2% ▲
5Y CAGR: +26.5%
Net Debt
$415M
+529.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $232M | $479M | $1.3B | $491M | $465M |
| Short-Term Investments | $0 | $16M | $114M | $77M | $70M |
| Cash & ST Investments | $232M | $495M | $1.4B | $567M | $535M |
| Net Receivables | $214M | $265M | $370M | $470M | $548M |
| Inventory | $298M | $364M | $570M | $635M | $671M |
| Other Current Assets | $50M | $65M | $146M | $91M | $225M |
| Total Current Assets | $794M | $1.2B | $2.5B | $1.9B | $2.0B |
| Property, Plant & Equip. | $425M | $672M | $1.0B | $1.4B | $1.7B |
| Goodwill & Intangibles | $36M | $105M | $222M | $207M | $189M |
| Long-Term Investments | $29M | $59M | $189M | $277M | $289M |
| Other Non-Current Assets | $26M | $106M | $213M | $52M | $147M |
| Total Non-Current Assets | $530M | $960M | $1.7B | $2.0B | $2.4B |
| Total Assets | $1.3B | $2.1B | $4.2B | $3.8B | $4.4B |
| — Liabilities — | |||||
| Accounts Payable | $82M | $162M | $338M | $223M | $295M |
| Short-Term Debt | $307M | $151M | $279M | $171M | $292M |
| Deferred Revenue | $126M | $184M | $526M | $0 | $0 |
| Other Current Liabilities | $1M | $15M | $858M | $433M | $229M |
| Total Current Liabilities | $521M | $512M | $1.5B | $841M | $1.1B |
| Long-Term Debt | $0 | $73M | $184M | $382M | $585M |
| Other Non-Current Liab. | $31M | $0 | $0 | $0 | $740K |
| Total Non-Current Liabilities | $39M | $111M | $233M | $431M | $656M |
| Total Liabilities | $559M | $624M | $1.8B | $1.3B | $1.7B |
| — Equity — | |||||
| Common Stock | $364M | $405M | $567M | $568M | $570M |
| Retained Earnings | $353M | $537M | $1.3B | $1.4B | $1.5B |
| Accumulated OCI | $37M | $58M | $190M | $227M | $252M |
| Total Stockholders Equity | $768M | $1.5B | $2.4B | $2.6B | $2.8B |
| Total Liabilities & Equity | $1.3B | $2.1B | $4.2B | $3.8B | $4.4B |
| — Key Metrics — | |||||
| Total Debt | $307M | $234M | $474M | $557M | $880M |
| Net Debt | $74M | -$245M | -$777M | $66M | $415M |
| Total Investments | $29M | $75M | $303M | $354M | $358M |